More than 18 years of experience as Chief Financial Officer and other C-level positions in life sciences, ranging from early-stage development to late-stage development companies

Entrepreneur-in-Residence at the Downstate Biotechnology Incubator where he advises new startups and early-stage drug development and medical device companies

Previously President and Chief Operating Officer of IRX Therapeutics, Inc. following a closing a strategic partnership with Celgene Corporation. As its Chief Financial Officer, he organized multiple capital raises in excess of $100 million

18 years in banking at J.P. Morgan, including an assignment in the corporate office

Experienced in all stages of the corporate lifecycle, including start-up operations, high growth, turnarounds and exit strategies. Expertise includes public and private financings, M&A, partnering / licensing transactions, and project management, and interactions with boards, venture capitalists and shareholders